Beijing Health (Holdings) Limited (02389.HK) Financial Statements

Income statement

Metric	TTM	2025	2024	2023	2022
Revenue
Total Revenue	264.1M	157.2M	149.9M	140.3M	166.5M
Cost of Revenue	207.2M	114.7M	114.3M	101.9M	120.0M
Gross Profit	56.9M	42.5M	35.7M	38.5M	46.5M
Operating Expenses
R&D Expense	—	—	—	—	—
SG&A Expense	178.9M	95.1M	34.6M	38.8M	112.0M
General & Admin Expense	117.2M	77.2M	25.0M	30.1M	97.4M
Selling & Marketing Expense	23.8M	17.9M	9.6M	8.7M	14.6M
Other Expenses	2.6M	1.3M	60.9M	65.6M	3.7M
Total Operating Expenses	181.6M	96.5M	95.5M	104.4M	115.7M
Cost and Expenses	390.4M	256.3M	209.7M	220.4M	242.0M
Operating Income (EBIT)	(126.3M)	(99.1M)	(65.1M)	(80.1M)	(75.6M)
Non-Operating
Interest Income	16.8M	19.0M	4.8M	15.6M	14.4M
Interest Expense	7.1M	2.5M	228.0K	376.0K	1.4M
Net Interest Income	9.8M	16.5M	4.6M	15.2M	13.0M
Other Non-Op Income/Expense	(89.8M)	(3.4M)	(54.3M)	11.3M	(27.1M)
Non-Operating Income (excl Interest)	8.0M	—	61.0M	5.2M	32.1M
EBT (Pre-Tax Income)	(216.1M)	(102.5M)	(119.4M)	(68.8M)	(102.7M)
Income Tax Expense	(2.4M)	477.0K	(3.8M)	(7.1M)	(3.9M)
Bottom Line
Net Income	(192.5M)	(100.9M)	(116.2M)	(61.9M)	(97.7M)
Earnings from Cont. Ops	(203.4M)	(102.0M)	(115.6M)	(61.7M)	(98.8M)
Earnings from Discont. Ops	—	—	—	—	—
Bottom Line Net Income	(192.5M)	(100.9M)	(116.2M)	(61.9M)	(97.7M)
Per Share
Basic EPS	(HK$0.03)	(HK$0.02)	(HK$0.02)	(HK$0.01)	(HK$0.02)
Diluted EPS	(HK$0.03)	(HK$0.02)	(HK$0.02)	(HK$0.01)	(HK$0.02)
Revenue Per Share	HK$0.04	HK$0.03	HK$0.02	HK$0.02	HK$0.03
Shares
Basic Shares Outstanding	6.1B	6.1B	6.1B	6.1B	6.1B
Diluted Shares Outstanding	6.1B	6.1B	6.1B	6.1B	6.1B
Profitability Metrics
EBITDA	(113.0M)	(77.4M)	(97.5M)	(44.2M)	(75.2M)
D&A	26.6M	21.7M	21.7M	24.2M	26.0M
EBIT	(139.6M)	(99.1M)	(119.2M)	(68.4M)	(101.3M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026